Search Results - "McFarland, Henry F."
-
1
Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria"
Published in Annals of neurology (01-12-2005)“…New diagnostic criteria for multiple sclerosis integrating magnetic resonance image assessment with clinical and other paraclinical methods were introduced in…”
Get full text
Journal Article -
2
The B Cell — Old Player, New Position on the Team
Published in The New England journal of medicine (14-02-2008)“…The benefits of therapies targeting B cells in autoimmune diseases have led to increased interest in the role of B cells in diseases that have been thought to…”
Get full text
Journal Article -
3
Recommendations for clinical use of data on neutralising antibodies to interferon-beta therapy in multiple sclerosis
Published in Lancet neurology (01-07-2010)“…Summary The identification of factors that can affect the efficacy of immunomodulatory drugs in relapsing-remitting multiple sclerosis (MS) is important. For…”
Get full text
Journal Article -
4
Thymic output generates a new and diverse TCR repertoire after autologous stem cell transplantation in multiple sclerosis patients
Published in The Journal of experimental medicine (07-03-2005)“…Clinical trials have indicated that autologous hematopoietic stem cell transplantation (HSCT) can persistently suppress inflammatory disease activity in a…”
Get full text
Journal Article -
5
Myelin basic protein-specific TCR/HLA-DRB501:01 transgenic mice support the etiologic role of DRB501:01 in multiple sclerosis
Published in The Journal of immunology (1950) (15-09-2012)“…Genetic susceptibility to multiple sclerosis (MS) has been linked to the HLA-DR15 haplotype consisting of DRB1*15:01(DR2b) and DRB5*01:01(DR2a) alleles. Given…”
Get full text
Journal Article -
6
Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis
Published in Annals of neurology (01-07-2001)“…The International Panel on MS Diagnosis presents revised diagnostic criteria for multiple sclerosis (MS). The focus remains on the objective demonstration of…”
Get full text
Journal Article -
7
Humanized Anti-CD25 (Daclizumab) Inhibits Disease Activity in Multiple Sclerosis Patients Failing to Respond to Interferon β
Published in Proceedings of the National Academy of Sciences - PNAS (08-06-2004)“…Identifying effective treatment combinations for MS patients failing standard therapy is an important goal. We report the results of a phase II open label…”
Get full text
Journal Article -
8
Multiple sclerosis: a complicated picture of autoimmunity
Published in Nature Immunology (01-09-2007)“…Understanding of autoimmune diseases, including multiple sclerosis, has expanded considerably in recent years. New insights have been provided by not only…”
Get full text
Journal Article -
9
Tissue Distribution and Variant Characterization of Human Herpesvirus (HHV)—6: Increased Prevalence of HHV-6A in Patients with Multiple Sclerosis
Published in The Journal of infectious diseases (01-11-2000)“…Human herpesvirus (HHV)—6 has been associated with the pathogenesis of multiple sclerosis (MS) on the basis of serologic, molecular, and histopathologic…”
Get full text
Journal Article -
10
Immunological Aspects of Demyelinating Diseases
Published in Annual review of immunology (01-01-1992)“…Primary demyelination in the central nervous system results from damage to the myelin sheath or oligodendroglia and can be produced by a variety of mechanisms,…”
Get full text
Journal Article -
11
Oral administration of the nitroxide radical TEMPOL exhibits immunomodulatory and therapeutic properties in multiple sclerosis models
Published in Brain, behavior, and immunity (01-05-2017)“…Highlights • The nitroxide radical TEMPOL given orally limits clinical disease in models of MS. • TEMPOL reduced inflammatory infiltrates and preserved…”
Get full text
Journal Article -
12
Immunotherapy of multiple sclerosis: Where are we? Where should we go?
Published in Nature immunology (01-09-2001)“…Differences in multiple sclerosis patient's disease and their responses to standard drugs indicate that today's therapies need to be more individualized. It is…”
Get full text
Journal Article -
13
Identification of endothelin 2 as an inflammatory factor that promotes central nervous system remyelination
Published in Brain (London, England : 1878) (01-04-2013)“…The development of new regenerative therapies for multiple sclerosis is hindered by the lack of potential targets for enhancing remyelination. The study of…”
Get full text
Journal Article -
14
Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: Results of a phase II clinical trial with an altered peptide ligand
Published in Nature medicine (01-10-2000)“…Myelin-specific T lymphocytes are considered essential in the pathogenesis of multiple sclerosis. The myelin basic protein peptide (a.a. 83-99) represents one…”
Get full text
Journal Article -
15
Evolution of T1 black holes in patients with multiple sclerosis imaged monthly for 4 years
Published in Brain (London, England : 1878) (01-08-2003)“…T1 black holes (BHs) on MRIs may represent either areas of oedema or axonal loss in patients with multiple sclerosis. BHs begin as contrast enhancing lesions…”
Get full text
Journal Article -
16
Alemtuzumab versus interferon beta-1a: implications for pathology and trial design
Published in Lancet neurology (2009)Get full text
Journal Article -
17
Gene expression profile in multiple sclerosis patients and healthy controls: identifying pathways relevant to disease
Published in Human molecular genetics (01-09-2003)“…Multiple sclerosis (MS) and other T cell-mediated autoimmune diseases develop in individuals carrying a complex susceptibility trait, probably following…”
Get full text
Journal Article -
18
Clustering of Non-Major Histocompatibility Complex Susceptibility Candidate Loci in Human Autoimmune Diseases
Published in Proceedings of the National Academy of Sciences - PNAS (18-08-1998)“…Human autoimmune diseases are thought to develop through a complex combination of genetic and environmental factors. Genome-wide linkage searches of autoimmune…”
Get full text
Journal Article -
19
Treatment with the phosphodiesterase type-4 inhibitor rolipram fails to inhibit blood—brain barrier disruption in multiple sclerosis
Published in Multiple sclerosis (01-10-2009)“…Rolipram, a prototypic phosphodiesterase-4 inhibitor, is highly effective in suppressing Th1 autoimmunity in multiple animal models, including experimental…”
Get full text
Journal Article -
20
Central nervous system disease in primary Sjögren’s syndrome: The role of magnetic resonance imaging
Published in Seminars in arthritis and rheumatism (01-12-2004)“…To examine the frequency of central nervous system (CNS) disease in primary Sjögren’s syndrome (pSS) and indicate ways in which cerebral magnetic resonance…”
Get full text
Journal Article